Stoke Therapeutics Inc (STOK) support and resistance · rev $36.6M
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
This page maps Stoke Therapeutics Inc (STOK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
STOK currently screens at market cap $1.88B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new STOK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the STOK quote page for the session range and the stock page for the full model.
Not investment advice.